News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
621,814 Results
Type
Article (48120)
Company Profile (223)
Press Release (573462)
Multimedia
Podcasts (92)
Webinars (17)
Section
Business (166652)
Career Advice (2547)
Deals (30373)
Drug Delivery (122)
Drug Development (78543)
Employer Resources (150)
FDA (14663)
Job Trends (13211)
News (295364)
Policy (28785)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2721)
Academic (1)
Accelerated approval (36)
Adcomms (31)
Allergies (149)
Alliances (43533)
ALS (186)
Alzheimer's disease (1769)
Antibody-drug conjugate (ADC) (355)
Approvals (14883)
Artificial intelligence (544)
Autoimmune disease (169)
Automation (41)
Bankruptcy (324)
Best Places to Work (10740)
BIOSECURE Act (19)
Biosimilars (181)
Biotechnology (166)
Bladder cancer (162)
Brain cancer (64)
Breast cancer (665)
Cancer (5061)
Cardiovascular disease (430)
Career advice (2150)
Career pathing (36)
CAR-T (298)
CDC (54)
Celiac Disease (2)
Cell therapy (784)
Cervical cancer (34)
Clinical research (67103)
Collaboration (1761)
Company closure (4)
Compensation (890)
Complete response letters (70)
COVID-19 (2741)
CRISPR (101)
C-suite (917)
Cystic fibrosis (147)
Data (6421)
Decentralized trials (2)
Denatured (20)
Depression (153)
Diabetes (506)
Diagnostics (6446)
Digital health (39)
Diversity (8)
Diversity, equity & inclusion (41)
Drug discovery (277)
Drug pricing (188)
Drug shortages (25)
Duchenne muscular dystrophy (251)
Earnings (63535)
Editorial (61)
Employer branding (20)
Employer resources (140)
Events (92024)
Executive appointments (1021)
FDA (17771)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (24)
Funding (1458)
Gene editing (217)
Generative AI (49)
Gene therapy (651)
GLP-1 (1020)
Government (4567)
Grass and pollen (7)
Guidances (386)
Healthcare (17406)
HIV (62)
Huntington's disease (52)
IgA nephropathy (87)
Immunology and inflammation (289)
Immuno-oncology (70)
Indications (121)
Infectious disease (3032)
Inflammatory bowel disease (212)
Inflation Reduction Act (16)
Influenza (120)
Intellectual property (257)
Interviews (530)
IPO (14126)
IRA (56)
Job creations (2835)
Job search strategy (1737)
JPM (60)
Kidney cancer (19)
Labor market (63)
Layoffs (547)
Leadership (39)
Legal (6098)
Liver cancer (97)
Longevity (15)
Lung cancer (689)
Lymphoma (384)
Machine learning (44)
Management (53)
Manufacturing (763)
MASH (179)
Medical device (11422)
Medtech (11472)
Mergers & acquisitions (17249)
Metabolic disorders (1319)
mRNA (172)
Multiple sclerosis (174)
NASH (23)
Neurodegenerative disease (356)
Neuropsychiatric disorders (100)
Neuroscience (3104)
Neurotech (1)
NextGen: Class of 2026 (5979)
Non-profit (4236)
Now hiring (59)
Obesity (612)
Opinion (295)
Ovarian cancer (169)
Pain (214)
Pancreatic cancer (238)
Parkinson's disease (299)
Partnered (33)
Patents (514)
Patient recruitment (516)
Peanut (55)
People (55338)
Pharmaceutical (36)
Pharmacy benefit managers (23)
Phase 1 (21153)
Phase 2 (29484)
Phase 3 (22099)
Pipeline (5580)
Policy (296)
Postmarket research (2409)
Preclinical (8880)
Press Release (59)
Prostate cancer (257)
Psychedelics (57)
Radiopharmaceuticals (300)
Rare diseases (937)
Real estate (4600)
Recruiting (63)
Regulatory (22660)
Reports (32)
Research institute (2419)
Resumes & cover letters (393)
Rett syndrome (28)
RNA editing (21)
RSV (80)
Schizophrenia (155)
Series A (245)
Series B (189)
Service/supplier (5)
Sickle cell disease (107)
Special edition (20)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (3236)
State (2)
Stomach cancer (20)
Supply chain (93)
Tariffs (77)
The Weekly (71)
Vaccines (1047)
Venture capital (90)
Weight loss (406)
Women's health (80)
Worklife (19)
Date
Today (157)
Last 7 days (679)
Last 30 days (2514)
Last 365 days (28840)
2026 (4301)
2025 (29041)
2024 (33414)
2023 (37547)
2022 (48356)
2021 (51962)
2020 (49766)
2019 (42559)
2018 (32211)
2017 (29388)
2016 (28178)
2015 (32753)
2014 (25037)
2013 (20812)
2012 (22143)
2011 (22838)
2010 (20403)
Location
Africa (801)
Alabama (81)
Alaska (5)
Arizona (236)
Arkansas (13)
Asia (37798)
Australia (7581)
California (10734)
Canada (3154)
China (1141)
Colorado (440)
Connecticut (440)
Delaware (334)
Europe (86410)
Florida (1620)
Georgia (324)
Hawaii (3)
Idaho (54)
Illinois (794)
India (67)
Indiana (496)
Iowa (18)
Japan (431)
Kansas (125)
Kentucky (34)
Louisiana (26)
Maine (61)
Maryland (1303)
Massachusetts (7655)
Michigan (299)
Minnesota (526)
Mississippi (4)
Missouri (127)
Montana (26)
Nebraska (24)
Nevada (113)
New Hampshire (78)
New Jersey (2872)
New Mexico (26)
New York (2804)
North Carolina (1349)
North Dakota (6)
Northern California (5283)
Ohio (298)
Oklahoma (12)
Oregon (39)
Pennsylvania (2128)
Puerto Rico (23)
Rhode Island (41)
South America (1068)
South Carolina (62)
South Dakota (1)
Southern California (4188)
Tennessee (149)
Texas (1701)
United States (37799)
Utah (337)
Vermont (1)
Virginia (261)
Washington D.C. (71)
Washington State (880)
West Virginia (4)
Wisconsin (107)
Wyoming (2)
621,814 Results for "ampliphi biosciences formerly known as targeted genetics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Targeted Genomics Launches Celiac Genetic Testing Services for Texas Physicians
February 2, 2026
·
2 min read
Press Releases
Angelini Pharma and Quiver Bioscience Announce Strategic Research Collaboration and Licensing Agreement to Discover and Advance Novel Therapeutics for Genetic Epilepsies
February 23, 2026
·
5 min read
Press Releases
Cellectar Biosciences Announces Strategic Supply Agreement with Ionetix for Actinium-225 and Astatine-211 to Advance Targeted Alpha Therapies
December 17, 2025
·
4 min read
Press Releases
insitro Completes First AI-Enabled Human Genetics Study of Brown Adipose Tissue, Shares Differentiated Targets with Anti-Obesity Effects
February 3, 2026
·
4 min read
Press Releases
Lilly to acquire Ventyx Biosciences to advance oral therapies targeting inflammatory-mediated diseases
January 8, 2026
·
11 min read
Press Releases
Jaguar Gene Therapy Announces Successful Completion of Dosing of First Patient Cohort in Clinical Trial Evaluating JAG201 for the Treatment of a Leading Monogenic Cause of Autism Spectrum Disorder Known as Phelan-McDermid Syndrome
February 24, 2026
·
11 min read
Press Releases
SK bioscience Initiates International Phase 1/2 Clinical Trial of Universal Vaccine Candidate Targeting Sarbecovirus Family
January 29, 2026
·
5 min read
Press Releases
Precision BioSciences Announces Presentation at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
February 18, 2026
·
5 min read
Press Releases
Neurocrine Biosciences Presents Head-to-Head INGREZZA® (valbenazine) Capsules Data Demonstrating Higher VMAT2 Target Occupancy Compared to AUSTEDO XR
January 16, 2026
·
14 min read
Press Releases
Cogent Biosciences Announces Multiple SUMMIT Posters at the 2026 AAAAI Annual Meeting
February 10, 2026
·
3 min read
1 of 62,182
Next
